Prominent European validator, Chorus One has joined Injective’s Equinox Staking testnet as a genesis validator.
Chorus One is one of the largest European validators today with more than $500M under management. The platform currently acts as a validator for leading projects in the space such as Solana, Polkadot, Near Protocol, The Graph, Chainlink, and many others. Chorus has also taken part in innovative tech solutions relating to interoperability, such as helping to facilitate a bridge between Cosmos SDK-based and Substrate-based blockchains.
Chorus One recently released Anthem which acts as a web application to track and manage your portfolio of Proof-of-Stake assets. Anthem provides stakers with a consistent, personalized dashboard that allows them to track, manage, and optimize how their staking assets are utilized on the Oasis and Celo network.
“The Injective Protocol has the potential to bring the non-custodial (DEX) trading experience up to par with centralized exchanges while maintaining a familiar interface for traders. This is a really important puzzle piece to enable a truly decentralized and open financial system and we are honored to be providing a part of the infrastructure to support this vision,” said Brian Fabian Crain, CEO and Co-Founder of Chorus One.
Chorus One will join a promising cohort of genesis validators on Injective. This further the community's mission to truly decentralize Injective moving forward. Contributors will be working closely with Chorus One both to expand staking capabilities and to test the security features of Injective.
About Chorus One
Chorus One is offering staking services and building protocols and tools to advance the Proof-of-Stake ecosystem.
They act as a validator with over $500m in assets for leading projects in the space such as Solana, Cosmos, Polkadot, Near Protocol, The Graph, Chainlink, and many others.
Injective is the first cross-chain protocol built for decentralized finance applications. On the Injective exchange, anyone can access, create, and trade unlimited DeFi markets such as futures and perpetuals. Developers can also build cross-chain Ethereum-compatible projects that are lightning fast and achieve instant transaction finality. Injective is backed by a prominent group of stakeholders including Binance, Pantera Capital and Mark Cuban.